Direktorat Registrasi ObatValid

RIVAROXABAN

Claim this product
BPOM Number
GKL2504532517A1
Approved
16 July 2025
Expiry
15 July 2030
Form
TABLET SALUT SELAPUT

About This Registration

RIVAROXABAN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2504532517A1. Its current registration status is Valid, with the licence valid until 15 July 2030. The product is registered to DARYA-VARIA LABORATORIA TBK - INDONESIA. BPOM first approved this registration in July 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 3 STRIPS @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

RIVAROXABAN

Market Intelligence

Owner Portfolio
DARYA-VARIA LABORATORIA TBK - INDONESIA holds 203 BPOM registrations
Manufacturer Scale
DARYA-VARIA LABORATORIA TBK - INDONESIA produces 203 registered products
Registration Age
Registered for 1 year, 1 month

FDA Cross-Reference

via openFDA
Generic Name
RIVAROXABAN
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from DARYA-VARIA LABORATORIA TBK - INDONESIA

SIDAVAR 50

-DKL2504532917A1
Valid
Approved: Dec 26, 2025TABLET SALUT SELAPUT
View product →

SITAGLIPTIN PHOSPHATE MONOHYDRATE

-GKL2504533017B1
Valid
Approved: Dec 26, 2025TABLET SALUT SELAPUT
View product →

SITAGLIPTIN PHOSPHATE MONOHYDRATE

-GKL2504533017A1
Valid
Approved: Dec 26, 2025TABLET SALUT SELAPUT
View product →

SIDAVAR 100

-DKL2504532917B1
Valid
Approved: Dec 26, 2025TABLET SALUT SELAPUT
View product →

ETORIX 90

-DKL2004529917A1
Valid
Approved: Dec 11, 2025TABLET SALUT SELAPUT
View product →

Products in the same class

VYTORIN

-LKE18066183
Valid
Approved: Apr 9, 2026TABLET
ORGANON PHARMA INDONESIA TBK - INDONESIA
View product →

ARCOXIA

-LKE20066194
Valid
Approved: Apr 7, 2026TABLET SALUT SELAPUT
ORGANON PHARMA INDONESIA TBK - INDONESIA
View product →

MYREPT

-DKI2584401309A1
Valid
Approved: Aug 31, 2025KAPLET SALUT SELAPUT
CKD OTTO PHARMACEUTICALS - INDONESIA
View product →

CORDEMA-G

-DKL2106321029A1
Valid
Approved: Aug 22, 2025KRIM
ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA
View product →

CHLORAMPHENICOL

-GKL9106306948A1
Valid
Approved: Jul 4, 2025TETES TELINGA
ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA
View product →
1